Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Mark Althoff Scribble in Hematopoietic Stem Cell Activity National Institutes of Health F31 HL132468 04/01/2016 - 03/31/2019 $36,972
Paul Andreassen, PhD A Novel and Rapid System to Classify BRCA2 Missense and Other Variants in Ovarian Cancer Department of Defense Army W81XWH1810269 06/15/2018 - 06/14/2021 $232,593
Paul Andreassen, PhD Therapeutic Targeting of Breast Cancer Stem Cells Ride Cincinnati Foundation BRCA2 09/01/2017 - 08/31/2018 $30,000
Laura Barreyro, PhD Training grant National Institutes of Health (University of Cincinnati) T32 ES007250 09/30/2015 - 09/29/2018 $40,671
Jose Cancelas-Perez
Carolyn M Lutzko		 G-CSF in Human Severe Congenital Neutropenia National Institutes of Health R01 GM110628 07/01/2015 - 06/30/2019 $308,100
Timothy M Chlon, PhD Modeling Tissue-specific Effects of Fanconi Anemia using human iPSC American Society of Hematology 2016ASHSCHOLAR 07/01/2016 - 06/30/2018 $50,000
Ashley E Cochran, PhD Training Grant National Institutes of Health (University of Cincinnati) T32 ES007250 12/01/2016 - 11/30/2018 $50,895
Robert A Coover, PhD Aberrant Purinergic Signaling in Neurofibromatosis Type 1 The Ohio State University Research Fnd Coover, Robert, OSU 10/01/2016 - 09/30/2018 $47,844
Marie-Dominique Filippi, PhD Molecular Regulation of Neutrophil Transcellular Migration' National Institutes of Health R01 GM112792 07/01/2015 - 06/30/2019 $308,100
Marie-Dominique Filippi, PhD
Punam Malik, MD		 Regulation of Hematopoietic Stem Cell Self-renewal by GTPase Activating Protein Signaling’ National Institutes of Health R01 DK102890 07/01/2015 - 06/30/2020 $416,320
Marie-Dominique Filippi, PhD Hypoxia and Potassium Channel Activity in T Lymphocytes National Institutes of Health (University of Cincinnati) R01 CA095286 07/01/2015 - 06/30/2018 $9,185
Jonathan Fletcher Cytokine Signaling in Neurofibroma Development National Institutes of Health F30 NS096796 03/01/2016 - 02/28/2018 $468
Matthew Flick, PhD Thrombin-dependent Mechanisms of Pancreatic Ductal Adenocarcinoma Disease National Institutes of Health R01 CA211098 06/19/2017 - 05/31/2022 $417,066
Matthew Flick, PhD Fungal Pathogenesis of Moderate to Severe Asthma National Institutes of Health (Baylor College of Medicine) R01 AI135803 03/23/2018 - 02/28/2023 $12,932
Matthew Flick, PhD Novel Anti-fibrotic Mechanisms in Chemical-induced Liver Injury National Institutes of Health (Michigan State University) RC105176CHMC 08/01/2015 - 06/30/2020 $35,766
Robert Francis Hennigan, PhD Identification of Novel Signaling Pathways in NF2 Department of Defense Army W81XWH1710152 07/01/2017 - 06/30/2019 $78,000
Cindy LF Hochstetler Impact of Abnormal Bone Marrow Endothelial Niche on Hematopoiesis National Institutes of Health F31 HL136229 03/01/2017 - 02/29/2020 $38,112
Jose Javier Active Transforming Growth Factor b1(aTGFb01) as a Predisposing Factor of B-acute Lymphoblastic Leukemia During Chronic Inflammatory Stress Ohio State University Comprehensive Canc 3343281 08/16/2017 - 08/15/2019 $31,992
Kakajan Komurov, PhD Exploiting Proteotoxic Stress in Therapy-refractory HER2+ Breast Cancers National Institutes of Health R01 CA193549 05/01/2015 - 04/30/2020 $356,850
Yuan Lin, PhD Therapeutic targeting of LARG-RhoA-ROCK Signaling Axis in Childhood Leukemia Cancer Free Kids Lin, Y, CFK 07/01/2017 - 06/30/2019 $50,000
Qing Richard Lu, PhD Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination National Institutes of Health R01 NS072427 09/20/2015 - 08/31/2020 $466,702
Qing Richard Lu, PhD Molecular and Signaling Mechanisms of Peripheral Nerve Sheath Tumorigenesis National Institutes of Health R37 NS096359 09/30/2016 - 08/31/2020 $529,965
Qing Richard Lu, PhD Chromatin Remodeling Control of Myelination and Remyelination National Institutes of Health R01 NS075243 09/15/2017 - 06/30/2022 $446,256
Qing Richard Lu, PhD The Establishment of Schwann Cell Polarity and the Inflation of Myelination National Institutes of Health (The Univ of California, San Francisco) R01 NS062796 05/01/2014 - 04/30/2019 $233,415
Qing Richard Lu, PhD Histone Deacetylase Control of CNS Myelination and Remyelination National Multiple Sclerosis Society Lu, Qing, NMSS 04/01/2015 - 03/31/2019 $254,168
Qing Richard Lu, PhD Long Non-coding RNA Control of CNS Myelination and Remyelination National Multiple Sclerosis Society RG150705671 04/01/2016 - 03/31/2019 $465,760
Qing Richard Lu, PhD Chd7 Chromatin Remodeller Function in Myelination and Remyelination National Multiple Sclerosis Society (Inserm Délégation Régionale Paris 6) RG150102851 10/01/2015 - 09/30/2018 $90,360
Daniel Lucas, PhD Cellular Crosstalk in the Hematopoietic Microenvironment National Institutes of Health R01 HL136529 05/04/2018 - 04/30/2022 $411,723
Punam Malik, MD
Jeffrey A Towbin, MD
Charles T Quinn, MD		 Cincinnati Center of Excellence in Hemoglobinopathies Research National Institutes of Health U01 HL117709 06/01/2016 - 05/31/2019 $659,602
Katelyn Melgar Novel Mechanisms and Therapeutic Strategies in Refractory Leukemia Cancer Free Kids Melgar, K, cfk 07/01/2017 - 06/30/2019 $50,000
Katelyn Melgar Novel Mechanisms and Therapeutic Strategies in Refractory Leukemia National Institutes of Health F31 CA217140 05/01/2017 - 04/30/2020 $37,672
Belal A Muhammad, PhD Exploiting Proteotoxic Stress in Pediatric Cancer Therapy Cancer Free Kids Muhammad, B,Cfk 07/01/2017 - 06/30/2018 $50,000
James Mulloy, PhD Leukemia Stem Cell Polarity and Differentiation Therapy National Institutes of Health R01 CA204895 09/01/2017 - 07/31/2022 $442,804
James Mulloy, PhD The Role of Hedgehog Signaling in Gastric Tissue Repair and Regeneration National Institutes of Health (University of Cincinnati) R01 DK083402 07/01/2016 - 04/30/2021 $43,234
Madeline R Niederkorn Uncovering Mechanisms of del(5q) MDS/AML Disease Progression Through the TIFAB-USP15 Signalosome Ohio State University Comprehensive Canc 3343281 08/16/2017 - 06/30/2018 $31,992
Qishen Pang, PhD FA DDR Pathway in Germline Integrity National Institutes of Health R01 HD089932 08/11/2017 - 03/31/2021 $329,925
Qishen Pang, PhD Role of FA Proteins in Hematopoiesis National Institutes of Health R01 HL076712 09/01/2017 - 05/31/2021 $795,000
Annmarie Ramkissoon, PhD A Novel Therapeutic Target for MPNS Cancer Free Kids Ramkisson,a,cfk 07/01/2017 - 06/30/2018 $40,000
Nancy Ratner, PhD Schwann Cell Interactions with the Neurofibroma Microenvironment Department of Defense Army W81XWH1710289 07/01/2017 - 06/30/2020 $298,999
Nancy Ratner, PhD Brain Dysfunction in Neurofibromatosis National Institutes of Health R01 NS091037 04/01/2015 - 03/31/2020 $309,792
Nancy Ratner, PhD Mitogenic Activities in Neurofibromatosis National Institutes of Health R01 NS028440 08/15/2017 - 06/30/2022 $416,303
Nancy Ratner, PhD Targeting Tumors with NF1 Loss National Institutes of Health (Trustees of Dartmouth) R01 NS095411 09/30/2015 - 07/31/2020 $108,311
Nancy Ratner, PhD Disordered Regulation of Wnt/?-catenin Signaling in MPNST Development and Maintenance National Institutes of Health (University of Minnesota) R01 NS086219 08/15/2014 - 06/30/2019 $274,835
Nancy Ratner, PhD An Innovative NF1 Drug Discovery Pipeline for Preclinical Development of Novel Drugs Quickly, Safely, and Effectively The Children's Tumor Foundation (The Children's Tumor Foundation) CTF 10/15/2015 - 11/30/2019 $75,891
Lilith Reeves Disseminating Curative Biological Therapies for Rare Pediatric Diseases National Institutes of Health (Children's Hospital Boston) GENFD0001351274 09/01/2016 - 08/31/2021 $149,733
Damien Reynaud, PhD Investigating the Mechanisms of Leukemia Initiation in the Context of Obesity Department of Defense Army W81XWH1510344 09/01/2015 - 08/31/2018 $187,200
Damien Reynaud, PhD Normal and Pathological Hematopoietic Stem Cells in Obesity National Institutes of Health R01 HL141418 04/01/2018 - 03/31/2022 $397,500
Navneet Kumar Singh, PhD Modelling and Targeting of Oncogenic Liability in Drug-Resistant Breast Cancer Department of Defense Army W81XWH1610028 03/01/2016 - 02/28/2019 $191,496
Molly Smith Aberrant Ubiquitin Editing in the Pathogenesis of Myeloid Malignancies National Institutes of Health F31 HL132420 09/01/2016 - 08/31/2020 $37,025
Daniel T. Starczynowski, PhD Decoding Innate Immune Signaling in Normal and Myelodysplastic Hematopoiesis National Institutes of Health R35 HL135787 01/10/2017 - 12/31/2023 $788,750
Daniel T. Starczynowski, PhD Targeting IRAK1/4 in Myelodysplastic Syndromes National Institutes of Health R01 DK113639 08/07/2017 - 05/31/2021 $977,026
Daniel T. Starczynowski, PhD Investigating Genetic and Molecular Determinants of Myelodysplastic Syndromes The Leukemia and Lymphoma Society 133416 07/01/2015 - 06/30/2020 $110,001
Daniel T. Starczynowski, PhD Rational Design of Dual IRAK1/4 Inhibitors as a New Therapy for MDS The Leukemia and Lymphoma Society 651117 10/01/2016 - 09/30/2019 $200,000
Ronald R Waclaw, PhD Signaling Pathways Regulating Oligodendrocyte Development and Function National Institutes of Health R01 NS088529 04/01/2015 - 02/29/2020 $341,250
Jianqiang Wu, MD miR-155 and RUNX Function in Neurofibroma Tumorigenesis and Therapy National Institutes of Health R01 NS097233 07/01/2016 - 06/30/2021 $341,250
Lai Man Wu, PhD Molecular and Signaling Mechanisms of Malignant Transformation in Peripheral Nerve Sheath Tumors The Children's Tumor Foundation 201701014 07/03/2017 - 07/02/2019 $53,999
Mark Wunderlich Therapeutic Insights through Patient Derived Leukemia Xenografts National Institutes of Health R50 CA211404 09/15/2016 - 08/31/2021 $172,232
Mei Xin, PhD Hippo Signaling in Heart Development and Repair National Institutes of Health R01 HL132211 04/01/2016 - 03/31/2021 $382,200
Yi Zheng, PhD Targeting Cdc42 for Bone Marrow Transplant Therapies National Institutes of Health R01 CA193350 05/01/2015 - 04/30/2020 $356,850
Yi Zheng, PhD Cdc42, Hematopoietic Stem Cell Polarity, and Cell Fate National Institutes of Health R01 DK104814 12/15/2015 - 11/30/2020 $685,620
Yi Zheng, PhD Blood Stem Cell Aging and Biomarker Studies National Institutes of Health R01 HL134617 08/01/2016 - 05/31/2020 $390,000
Yi Zheng, PhD Targeting TET1 Signaling to Treat Acute Myeloid Leukemia National Institutes of Health (City of Hope) R01 CA211614 01/01/2018 - 12/31/2021 $61,776
Yi Zheng, PhD Activated Protein C Peptides for Radio-mitigation National Institutes of Health (P2D Bioscience) R43 AI127065 04/14/2017 - 03/31/2019 $67,681
Total Annual Grant Award Dollars $15,306,164

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Matthew Flick, PHD Fibriant, B.V. $68,107
Punam Malik, MD Calimmune Inc $299,192
Total Annual Industry Award Dollars $367,299